Skip to main content
Log in

Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

A Correction to this article was published on 23 March 2021

This article has been updated

Abstract

Objectives

To define the incidence of high residual gradient (HRG) after transcatheter aortic valve replacement (TAVR) in BAVs and their impact on short term outcome and 1-year mortality.

Background

Transcatheter heart valves (THVs) offer good performance in tricuspid aortic valves with low rate of HRG. However, data regarding their performance in bicuspid aortic valves (BAV) are still lacking.

Methods

The BEAT (Balloon vs Self-Expandable valve for the treatment of bicuspid Aortic valve sTenosis) registry included 353 consecutive patients who underwent TAVR (Evolut R/PRO or Sapien 3 valves) in BAV between June 2013 and October 2018. The primary endpoint was device unsuccess with post-procedural HRG (mean gradient ≥ 20 mmHg). The secondary endpoint was to identify the predictors of HRG following the procedure.

Results

Twenty patients (5.6%) showed HRG after TAVR. Patients with HRG presented higher body mass index (BMI) (30.7 ± 9.3 vs. 25.9 ± 4.8; p < 0.0001) and higher baseline aortic mean gradients (57.6 ± 13.4 mmHg vs. 47.7 ± 16.6, p = 0.013) and more often presented with BAV of Sievers type 0 than patients without HRG. At multivariate analysis, BMI [odds ratio (OR) 1.12; 95% confidence interval (CI) 1.05–1.20, p = 0.001] and BAV type 0 (OR 11.31, 95% CI 3.45–37.06, p < 0.0001) were confirmed as independent predictors of high gradient.

Conclusion

HRG following TAVR in BAVs is not negligible and is higher among patients with high BMI and with BAV 0 anatomy.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

Abbreviations

HRG:

High residual gradient

THV:

Transcatheter heart valve

TAVI:

Transcatheter aortic valve implantation

TAVR:

Transcatheter aortic valve replacement

BAV:

Bicuspid aortic valves

VARC:

Valve Academic Research Consortium

BMI:

Body mass index

OR:

Odds ratio

CI:

Confidence interval

PAR:

Paravalvular aortic regurgitation

References

  1. Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380(18):1695–1705

    Article  Google Scholar 

  2. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620

    Article  CAS  Google Scholar 

  3. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607

    Article  CAS  Google Scholar 

  4. Kawamori H, Yoon SH, Chakravarty T et al (2018) Computed tomography characteristics of the aortic valve and the geometry of SAPIEN 3 transcatheter heart valve in patients with bicuspid aortic valve disease. Eur Heart J Cardiovasc Imaging 19(12):1408–1418

    Article  Google Scholar 

  5. Sievers HH, Schmidtke C (2007) A classification system for the bicuspid aortic valve from 304 surgical specimens. J ThoracCardiovascSurg 133(5):1226–1233

    Google Scholar 

  6. Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33(19):2403–2418

    Article  Google Scholar 

  7. Kappetein AP, Head SJ, Généreux P et al (2013) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J ThoracCardiovascSurg 145(1):6–23

    Google Scholar 

  8. Mangieri A, Chieffo A, Won-Keun W et al (2018) Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. EuroIntervention 14(12):e1269–e1275

    Article  Google Scholar 

  9. Halim SA, Edwards FH, Dai D et al (2020) Outcomes of transcatheter aortic valve replacement in patients with bicuspid aortic valve disease: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation 141(13):1071–1079

    Article  Google Scholar 

  10. Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HCM et al (2016) Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement multicenter registry. J Am Coll Cardiol 67(6):644–655

    Article  Google Scholar 

  11. Yousef A, Simard T, Webb JA et al (2015) Transcatheter aortic valve implantation in patients with bicuspid aortic valve: a patient level multi-center analysis. Int J Cardiol 189:282–288

    Article  Google Scholar 

  12. Yoon SH, Bleiziffer S, De Backer O et al (2017) Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol 69(21):2579–2589

    Article  Google Scholar 

  13. Freitas-Ferraz AB, Tirado-Conte G, Dagenais F et al (2019) Aortic stenosis and small aortic annulus. Circulation 139(23):2685–2702

    Article  Google Scholar 

  14. Miyasaka M, Tada N, Taguri M, OCEAN-TAVI Investigators et al (2018) Incidence, predictors, and clinical impact of prosthesis-patient mismatch following transcatheter aortic valve replacement in asian patients: the OCEAN-TAVI registry. J Am Coll CardiolIntv 11(8):771–780

    Article  Google Scholar 

  15. Fallon JM, DeSimone JP, Brennan JM et al (2018) The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement. Ann ThoracSurg 106(1):14–22

    Article  Google Scholar 

  16. Martin C, Sun W (2017) Transcatheter valve underexpansion limits leaflet durability: implications for valve-in-valve procedures. Ann Biomed Eng 45(2):394–404

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Mangieri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This is an observational study and was conducted from data obtained for clinical purposes. The BEAT (Balloon vs Self-Expandable valve for the treatment of bicuspid Aortic valve sTenosis) registry has been approved by local Ethical Committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

The original online version of this article was revised: The original version of this article, published on January 3, 2021, contained a mistake. The spelling of Arif Khokhar’s name was incorrect. The original article has been corrected.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bugani, G., Pagnesi, M., Tchetchè, D. et al. Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Clin Res Cardiol 110, 667–675 (2021). https://doi.org/10.1007/s00392-020-01793-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-020-01793-9

Keywords

Navigation